Tagged eastgate-biotech

Press Release

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

 Investment and Product License includes licensing fee and development costs Read More
Press Release

EastGate Biotech Announces Joint Venture With Netris/Origin Biopharmaceuticals for Pakistani Market

 Drug Development and Nutraceuticals Covered in JV. Read More
Press Release

EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation

 EastGate to receive funding in tranches up to $5 million USD. Read More
Press Release

EastGate Biotech Announces that It Has Reached a Definitive Settlement Agreement with Northbridge Financial Inc.

 The Share Reserve with Transfer Agent has been cancelled and all remaining shares have been returned to EastGate Biotech. Read More
Press Release

EastGate Biotech Enters Into a MOU with Genluiching Mining Corp. and AAH & International Associates Inc. of the Philippines

 Read More
Press Release

EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients

 Read More
Press Release

Eastgate Biotech Provides Corporate Update

 Read More
Press Release

EastGate Biotech Announces Annual Report Form 10-K Filing

 Read More
Press Release

EastGate Biotech Announces Opening of Representative Office in the Philippines

 Read More
Press Release

EastGate Biotech Announces Engagement of the Kell Group Limited for Introduction to Various Sources of Funding for Company Initiatives

 The Kell Group Limited served as an agent for related-party advances. Read More
Press Release

Eastgate Biotech Engages Agent to Identify Suitable Joint Venture Partners and Suppliers in the Philippines

 Mandate also includes collaboration with local hospital for innovative Surgical and Anti-Aging procedures Read More